A single wrong letter in a three-billion-letter genetic code can turn a life-saving oxygen carrier into a molecule that clogs blood vessels or shortens the life of red blood cells. That is the story of haemoglobin variants. These are not rare curiosities confined to textbooks; they affect a meaningful share of India’s population and shape how doctors screen couples before marriage, test newborns and manage anaemia. Understanding where these variants come from, how they get their unusual names and how labs actually detect them makes the rest of population genetics click into place.
Table of Contents
- What counts as a haemoglobin variant?
- How do haemoglobin variants actually arise?
- Missense mutations
- Deletions
- Antitermination mutations
- Multiple amino acid substitutions
- Post-translational modifications
- Why are haemoglobin variants named after places?
- How labs actually identify a haemoglobin variant
- Clinical examination first
- Haemoglobin separation techniques
- Electrophoresis and chromatography in practice
- Functional and stability tests
- Mass spectrometry, DNA sequencing and crystallography
- Four clinically significant variants worth knowing
- HbS: sickle cell haemoglobin
- HbE: the world’s most common structural variant
- HbC: geographically restricted but biologically distinct
- HbD: the Punjab connection
What counts as a haemoglobin variant?
Normal adult haemoglobin (HbA) is built from two alpha and two beta globin chains folded around an iron-containing heme group. A haemoglobin variant is what you get when a change in the DNA sequence of a globin gene alters the protein itself, producing a structurally different haemoglobin molecule. This is distinct from thalassaemia, where the problem is reduced quantity of an otherwise normal globin chain rather than an altered structure. Variants can be harmless, mildly disruptive or, in a few well-known cases, the cause of serious disease.
How do haemoglobin variants actually arise?
Globin gene mutations are common enough to affect a large fraction of people worldwide, and the mechanisms behind them fall into a handful of recognisable categories, as detailed in a widely cited review of haemoglobin variant biochemistry and clinical correlates.
Missense mutations
This is by far the most frequent cause. A single nucleotide change in the globin gene swaps one amino acid for another in the finished protein. HbS, HbC and HbE all arise this way, each from a different single-letter change in the beta globin gene.
Deletions
Some variants result from a stretch of DNA being dropped out of the gene entirely. This can remove amino acids from the middle of the chain or fuse parts of two different genes together, producing a hybrid protein.
Antitermination mutations
Every gene has a “stop” signal that tells the cell where to end the protein chain. A mutation at this stop codon causes the ribosome to keep reading past it, producing an abnormally long globin chain. Hb Constant Spring, an elongated alpha chain variant common in Southeast Asia, is the textbook example.
Multiple amino acid substitutions
Occasionally more than one amino acid is altered in the same chain, either from two separate mutations on the same gene copy or from gene recombination during cell division.
Post-translational modifications
Not every variant originates in the DNA. Some arise after the protein is made, when chemical groups attach to the finished globin chain and change its properties. These acquired variants are less common but well documented.
Taken together, these mechanisms have produced an enormous catalogue of documented variants. Specialised reference databases such as HbVAR and ithanet now list more than 1,800 distinct haemoglobin gene variants across the alpha, beta and related globin genes, most of which are rare and clinically silent.
Why are haemoglobin variants named after places?
If you have come across names like Hb-Lepore, HbD-Punjab or Hb-Chicago, you might wonder why haemoglobin nomenclature reads like a travel itinerary. The convention is straightforward: a newly discovered variant is typically named after the family or the geographic region of the first person in whom it was identified, rather than after a biochemical code that would mean little to clinicians.
This system has practical value. A name like HbD-Punjab immediately hints at where the variant is commonly found, which helps doctors decide which additional tests to order in a patient from that region. It also has a historical quirk: the same variant can sometimes be identified independently in different parts of the world and given more than one geographic name before scientists confirm it is the same mutation. HbD, for instance, has been reported under several different place-based names before genetic testing clarified that many of these were the same underlying change, with Hb D-Punjab remaining the most prevalent form, found not only across Punjab but also reported in parts of Europe.
How labs actually identify a haemoglobin variant
Suspecting a haemoglobin variant is one thing; confirming exactly which one a patient carries requires a stepwise investigation, moving from simple bedside clues to precise molecular confirmation.
Clinical examination first
Pallor, jaundice, an enlarged spleen or a family history of anaemia often gives the first clue. This is rarely enough on its own, but it tells the clinician which laboratory tests to prioritise.
Haemoglobin separation techniques
Once blood is drawn, the goal is to separate the different haemoglobin types present in the sample. According to a detailed review of molecular diagnosis of thalassaemias and haemoglobinopathies, presumptive identification of a variant is usually achieved through gel electrophoresis, isoelectric focusing, high-performance liquid chromatography (HPLC) or capillary zone electrophoresis, comparing the pattern against known reference variants.
Electrophoresis and chromatography in practice
Electrophoresis separates haemoglobin molecules based on their electrical charge, while HPLC separates them based on how they interact with a chromatography column. In Indian laboratories, HPLC has effectively become the workhorse test because it can identify and quantify several haemoglobin fractions from a single blood sample in a matter of minutes, making it practical for large-scale premarital and antenatal screening programmes.
Functional and stability tests
Beyond structure, some variants are tested for how they behave. A haemoglobin-oxygen binding curve shows whether a variant binds oxygen too tightly or releases it too easily, which can cause unexplained polycythaemia or cyanosis even when the red blood cell count looks normal. Visible wavelength spectroscopy examines how a haemoglobin sample absorbs light at specific wavelengths, useful for detecting altered forms like methaemoglobin. Stability testing exposes the haemoglobin to heat or chemical stress to see if it denatures faster than normal, which is how unstable variants causing chronic haemolysis are flagged.
Mass spectrometry, DNA sequencing and crystallography
When electrophoresis and chromatography patterns are ambiguous, laboratories turn to more precise tools. Mass spectrometry can pinpoint the exact molecular weight change caused by an amino acid substitution. DNA sequencing, particularly Sanger sequencing of the globin genes, gives a definitive answer at the genetic level and is now routinely combined with HPLC in Indian screening studies, including recent community-based work profiling rare variants among the Tharu population of Uttar Pradesh using HPLC alongside Sanger sequencing to confirm suspected cases. Crystallography, which reveals the three-dimensional structure of the haemoglobin molecule, is reserved mainly for research settings where scientists need to understand exactly how a mutation changes the protein’s shape and function.
Four clinically significant variants worth knowing
HbS: sickle cell haemoglobin
HbS results from a single point mutation in the beta globin gene where glutamic acid is replaced by valine at the sixth position of the chain, as confirmed in molecular studies of sickle cell disease genetics and pathophysiology. Under low oxygen conditions, this substitution causes HbS molecules to polymerise into rigid fibres, distorting red blood cells into the characteristic sickle shape and triggering blocked blood vessels and chronic anaemia. In India, the sickle cell gene is concentrated in tribal populations across central India, including parts of Madhya Pradesh, Chhattisgarh, Odisha and Maharashtra.
HbE: the world’s most common structural variant
HbE arises from a different substitution on the beta chain and is remarkably common, with its distribution running from eastern India through Southeast Asia, peaking in an area near the Thai-Vietnamese border sometimes called the “haemoglobin E triangle,” where carrier rates reach 25 to 30 percent. On its own, HbE carrier status is usually mild, but when co-inherited with beta thalassaemia, it produces HbE-beta thalassaemia, one of the more severe and common haemoglobinopathies seen in eastern Indian states.
HbC: geographically restricted but biologically distinct
HbC results from a different amino acid change at the same position affected in HbS. It reduces the solubility of haemoglobin inside red blood cells, causing crystals to form and shortening cell lifespan, though it does not polymerise the way HbS does. It remains largely confined to West Africa, where gene frequencies reach roughly 25 percent in some populations, and is uncommon in India.
HbD: the Punjab connection
HbD-Punjab, the most frequently encountered form of HbD, carries clinical significance mainly when paired with HbS or beta thalassaemia, since HbD alone tends to behave like a relatively benign trait. Its regional name reflects where it was most extensively documented, and Indian genetic screening programmes continue to pick up cases, particularly in northern states.
What do you think? If naming conventions favour geography over biochemistry, how might that affect how quickly two independently discovered variants get recognised as genetically identical? And given how much HPLC has simplified large-scale screening in India, do you think DNA sequencing will eventually become affordable enough to replace it as the first-line test rather than the confirmatory one?
References
- https://perspectivesinmedicine.cshlp.org/content/3/3/a011858.full.pdf
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12390978/
- https://www.sciencedirect.com/science/article/abs/pii/S0009898115001060
- https://academic.oup.com/ajcp/article/148/1/6/3866692
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12428004/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510211/
- https://www.sciencedirect.com/topics/medicine-and-dentistry/hemoglobin-variant
Leave a Reply